Table 2 Characteristics of post-dUCBT... | American Society of Hematology

Table 2

Characteristics of post-dUCBT patient PBMC samples

Patient no.	Months post-dUCBT	Donor T-cell chimerism*	CD3⁺ cells (10⁹/L)	CD3⁺CD4⁺ cells (% of T cells)
1	2.1	>95% D2	0.226	88.9
1	2.9	>95% D2	0.166	96.4
2	2.1	>95% D1	0.487	80.1
2	3.4	>95% D1	0.699	94.1
3	2.0	>95% D2	0.093	69.9
3	3.9	ND†	0.282	67.4
4	1.1	>95% D1	0.546	58.4
5	1.1	>95% D2	0.139	93.5
6	2.0	ND†	0.072	73.6
6	3.0	>95% D2	0.442	58.8
6	6.0	>95% D2	0.290	40.7
7	3.5	ND†, 92% R	0.034	88.2
7	6.7	2% D1, <5% D2†	0.030	86.7
8	5.3	>95% D1	0.155	91.0
9	2.1	>95% D1	0.207	68.1
10	1.1	>95% D2	0.059	72.9
10	2.1	>95% D2	0.211	74.4
11	1.1	>95% D1	0.102	66.6
11	2.8	>95% D1	0.452	41.8

Patient no.	Months post-dUCBT	Donor T-cell chimerism*	CD3⁺ cells (10⁹/L)	CD3⁺CD4⁺ cells (% of T cells)
1	2.1	>95% D2	0.226	88.9
1	2.9	>95% D2	0.166	96.4
2	2.1	>95% D1	0.487	80.1
2	3.4	>95% D1	0.699	94.1
3	2.0	>95% D2	0.093	69.9
3	3.9	ND†	0.282	67.4
4	1.1	>95% D1	0.546	58.4
5	1.1	>95% D2	0.139	93.5
6	2.0	ND†	0.072	73.6
6	3.0	>95% D2	0.442	58.8
6	6.0	>95% D2	0.290	40.7
7	3.5	ND†, 92% R	0.034	88.2
7	6.7	2% D1, <5% D2†	0.030	86.7
8	5.3	>95% D1	0.155	91.0
9	2.1	>95% D1	0.207	68.1
10	1.1	>95% D2	0.059	72.9
10	2.1	>95% D2	0.211	74.4
11	1.1	>95% D1	0.102	66.6
11	2.8	>95% D1	0.452	41.8

Predominant donor 1 (D1) or D2 CBU; method STR PCR analysis on magnetic-activated cell sorting–sorted peripheral blood CD3⁺ T cells.

No data (ND) T-cell chimerism, but PB/BM >95% D2 (patient 3, patient 6); PB/BM >95% D1 (pat 7).